跳至主要内容
临床试验/CTRI/2012/12/003264
CTRI/2012/12/003264已完成4 期

A parallel, randomized, comparative, double-blind, double-dummy clinical trial to evaluate the efficacy and safety of Troxipide versus Rabeprazole in the Treatment of Gastritis & Gastric Ulcer

Zuventus Healthcare Ltd0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1.Male or female patients aged 18 years or older.
  • 2.Clinical symptoms and endoscopic diagnosis of gastric mucosal injury (erosion/ oozing/redness/edema) as in gastritis (acute or acute exacerbation of chronic gastritis) and/or gastric ulcers (Patients with endoscopically diagnosed A1- or A2-stage ulcer (by Sakita/Miwa classification).
  • 3.Patients willing to give written informed consent and willing to comply with trial protocol.
  • 4.Patients who are on therapy with PPI, H2RAs, NSAIDs, muscarinic antagonists or other gastroprotective agents, but who have undergone a washout period of 7 days wherein only oral antacids are taken.

排除标准

  • 未提供

研究者

相似试验